238 related articles for article (PubMed ID: 32945424)
41. miR-217 inhibits the migration and invasion of HeLa cells through modulating MAPK1.
Zhu L; Yang S; Wang J
Int J Mol Med; 2019 Nov; 44(5):1824-1832. PubMed ID: 31485607
[TBL] [Abstract][Full Text] [Related]
42. MicroRNA‑199b promotes cell proliferation and invasion in Wilms' tumour by directly targeting Runt‑related transcription factor 3.
Zhao H; Zhao H; Zhang Y; Zhou Y
Mol Med Rep; 2018 Aug; 18(2):1812-1819. PubMed ID: 29845298
[TBL] [Abstract][Full Text] [Related]
43. MicroRNA-494 acts as a tumor suppressor in pancreatic cancer, inhibiting epithelial-mesenchymal transition, migration and invasion by binding to SDC1.
Yang Y; Tao X; Li CB; Wang CM
Int J Oncol; 2018 Sep; 53(3):1204-1214. PubMed ID: 29956739
[TBL] [Abstract][Full Text] [Related]
44. miR‑302c‑3p and miR‑520a‑3p suppress the proliferation of cervical carcinoma cells by targeting CXCL8.
Ding HM; Zhang H; Wang J; Zhou JH; Shen FR; Ji RN; Shi JY; Chen YG
Mol Med Rep; 2021 May; 23(5):. PubMed ID: 33760117
[TBL] [Abstract][Full Text] [Related]
45. MiR-1266 promotes cell proliferation, migration and invasion in cervical cancer by targeting DAB2IP.
Wang J; Liu Y; Wang X; Li J; Wei J; Wang Y; Song W; Zhang Z
Biochim Biophys Acta Mol Basis Dis; 2018 Dec; 1864(12):3623-3630. PubMed ID: 30261286
[TBL] [Abstract][Full Text] [Related]
46. MiR-144 suppresses proliferation, invasion, and migration of breast cancer cells through inhibiting CEP55.
Yin Y; Cai J; Meng F; Sui C; Jiang Y
Cancer Biol Ther; 2018 Apr; 19(4):306-315. PubMed ID: 29561704
[TBL] [Abstract][Full Text] [Related]
47. MicroRNA-492 overexpression involves in cell proliferation, migration, and radiotherapy response of cervical squamous cell carcinomas.
Liu M; An J; Huang M; Wang L; Tu B; Song Y; Ma K; Wang Y; Wang S; Zhu H; Xu N; Wu L
Mol Carcinog; 2018 Jan; 57(1):32-43. PubMed ID: 28802022
[TBL] [Abstract][Full Text] [Related]
48. Expression of the lncRNA ZFAS1 in cervical cancer and its correlation with prognosis and chemosensitivity.
Feng LL; Shen FR; Zhou JH; Chen YG
Gene; 2019 May; 696():105-112. PubMed ID: 30738960
[TBL] [Abstract][Full Text] [Related]
49. MiR-200b promotes the cell proliferation and metastasis of cervical cancer by inhibiting FOXG1.
Zeng F; Xue M; Xiao T; Li Y; Xiao S; Jiang B; Ren C
Biomed Pharmacother; 2016 Apr; 79():294-301. PubMed ID: 27044840
[TBL] [Abstract][Full Text] [Related]
50. hsa_circ_0101119 facilitates the progression of cervical cancer via an interaction with EIF4A3 to inhibit TCEAL6 expression.
Sui X; Wang Y; Liu H
Mol Med Rep; 2021 Sep; 24(3):. PubMed ID: 34278492
[TBL] [Abstract][Full Text] [Related]
51. MicroRNA‑15a‑5p‑targeting oncogene YAP1 inhibits cell viability and induces cell apoptosis in cervical cancer cells.
Chen X; Cao R; Liu H; Zhang T; Yuan X; Xu S
Int J Mol Med; 2020 Oct; 46(4):1301-1310. PubMed ID: 32945353
[TBL] [Abstract][Full Text] [Related]
52. Long non‑coding RNA CASC2 suppresses pancreatic cancer cell growth and progression by regulating the miR‑24/MUC6 axis.
Xu DF; Wang LS; Zhou JH
Int J Oncol; 2020 Feb; 56(2):494-507. PubMed ID: 31894271
[TBL] [Abstract][Full Text] [Related]
53. LncRNA TDRG1 promotes the proliferation, migration, and invasion of cervical cancer cells by sponging miR-214-5p to target SOX4.
Guo M; Lin B; Li G; Lin J; Jiang X
J Recept Signal Transduct Res; 2020 Jun; 40(3):281-293. PubMed ID: 32106739
[TBL] [Abstract][Full Text] [Related]
54. FOXD3‑AS1/miR‑128‑3p/LIMK1 axis regulates cervical cancer progression.
Yang X; Du H; Bian W; Li Q; Sun H
Oncol Rep; 2021 May; 45(5):. PubMed ID: 33760158
[TBL] [Abstract][Full Text] [Related]
55. miR-130a acts as a potential diagnostic biomarker and promotes gastric cancer migration, invasion and proliferation by targeting RUNX3.
Jiang H; Yu WW; Wang LL; Peng Y
Oncol Rep; 2015 Sep; 34(3):1153-61. PubMed ID: 26134263
[TBL] [Abstract][Full Text] [Related]
56. Serum miR-486-5p as a diagnostic marker in cervical cancer: with investigation of potential mechanisms.
Li C; Zheng X; Li W; Bai F; Lyu J; Meng QH
BMC Cancer; 2018 Jan; 18(1):61. PubMed ID: 29316891
[TBL] [Abstract][Full Text] [Related]
57. MiR-4319 targets tuftelin 1 to reduce malignancy of cervical cancer cells.
Zheng L; Ren Q; Zhu W; Tao X; Guo L
Cell Mol Biol (Noisy-le-grand); 2024 Mar; 70(3):54-60. PubMed ID: 38650156
[TBL] [Abstract][Full Text] [Related]
58. Tumor suppressor miR-192-5p targets TRPM7 and inhibits proliferation and invasion in cervical cancer.
Dong RF; Zhuang YJ; Wang Y; Zhang ZY; Xu XZ; Mao YR; Yu JJ
Kaohsiung J Med Sci; 2021 Aug; 37(8):699-708. PubMed ID: 34042256
[TBL] [Abstract][Full Text] [Related]
59. MiR-29a inhibits cell proliferation and migration by targeting the CDC42/PAK1 signaling pathway in cervical cancer.
Chen R; Zhang L
Anticancer Drugs; 2019 Jul; 30(6):579-587. PubMed ID: 30724771
[TBL] [Abstract][Full Text] [Related]
60. RUNX3 inhibits laryngeal squamous cell carcinoma malignancy under the regulation of miR-148a-3p/DNMT1 axis.
Jili S; Eryong L; Lijuan L; Chao Z
Cell Biochem Funct; 2016 Dec; 34(8):597-605. PubMed ID: 27859417
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
